Lynda Wilton

1.8k total citations
48 papers, 1.3k citations indexed

About

Lynda Wilton is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lynda Wilton has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pediatrics, Perinatology and Child Health, 11 papers in Psychiatry and Mental health and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lynda Wilton's work include Pharmaceutical studies and practices (13 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Lynda Wilton is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Lynda Wilton collaborates with scholars based in United Kingdom, Hong Kong and United States. Lynda Wilton's co-authors include Saad Shakir, Ian Chi Kei Wong, Gillian Pearce, W.H.W. Inman, Suzanne McCarthy, Macey L. Murray, Paul Hodgkins, Philip Asherson, Ronald D. Mann and Kiyoshi Kubota and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Clinical Epidemiology and The Journal of Clinical Psychiatry.

In The Last Decade

Lynda Wilton

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynda Wilton United Kingdom	20	409	340	319	165	150	48	1.3k
John P. Ney United States	17	217 0.5×	205 0.6×	594 1.9×	54 0.3×	238 1.6×	77	1.7k
Barbara A. Liu Canada	15	615 1.5×	87 0.3×	148 0.5×	134 0.8×	160 1.1×	22	1.6k
Brenda Breuer United States	24	146 0.4×	265 0.8×	392 1.2×	51 0.3×	248 1.7×	43	1.5k
Geana Paula Kurita Denmark	22	172 0.4×	388 1.1×	608 1.9×	50 0.3×	248 1.7×	91	1.5k
Eric Schirm Netherlands	15	201 0.5×	529 1.6×	163 0.5×	57 0.3×	63 0.4×	21	854
Ji Eun Lee South Korea	22	165 0.4×	76 0.2×	274 0.9×	80 0.5×	189 1.3×	84	1.3k
Jacquelyn Bainbridge United States	21	1.0k 2.5×	787 2.3×	125 0.4×	73 0.4×	117 0.8×	54	2.0k
Edgar H. Adams United States	21	183 0.4×	189 0.6×	553 1.7×	50 0.3×	238 1.6×	32	1.4k
Christopher W. Forsberg United States	26	166 0.4×	111 0.3×	209 0.7×	35 0.2×	142 0.9×	45	1.8k
Christine Leong Canada	17	211 0.5×	104 0.3×	192 0.6×	100 0.6×	84 0.6×	58	852

Countries citing papers authored by Lynda Wilton

Since Specialization

Citations

This map shows the geographic impact of Lynda Wilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Wilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Wilton more than expected).

Fields of papers citing papers by Lynda Wilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Wilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Wilton. The network helps show where Lynda Wilton may publish in the future.

Co-authorship network of co-authors of Lynda Wilton

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Wilton. A scholar is included among the top collaborators of Lynda Wilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Wilton. Lynda Wilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rashed, Asia N, et al.. (2013). Epidemiology and potential risk factors of drug‐related problems in Hong Kong paediatric wards. British Journal of Clinical Pharmacology. 77(5). 873–879. 51 indexed citations

Wilton, Lynda, et al.. (2013). Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England. Drug Safety. 36(4). 237–246. 21 indexed citations

Star, Kristina, Noha Iessa, Noor B. Almandil, et al.. (2012). Rhabdomyolysis Reported for Children and Adolescents Treated with Antipsychotic Medicines: A Case Series Analysis. Journal of Child and Adolescent Psychopharmacology. 22(6). 440–451. 32 indexed citations

Rashed, Asia N, Antje Neubert, Stephen Tomlin, et al.. (2012). Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia. European Journal of Clinical Pharmacology. 68(12). 1657–1666. 58 indexed citations

Iessa, Noha, Kristina Star, Lynda Wilton, et al.. (2011). Montelukast and Suicide: Causality Assessment Using Spontaneous Reports and Bradford Hill Guidelines. Drug Safety. 34. 949–950. 2 indexed citations

Buggy, Y., Victoria Cornelius, Lynda Wilton, & Saad Shakir. (2011). Risk of Depressive Episodes with Rimonabant. Drug Safety. 34(6). 501–509. 19 indexed citations

Wilton, Lynda, et al.. (2011). Paediatric post‐marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults. Pharmacoepidemiology and Drug Safety. 20(6). 608–618. 8 indexed citations

Osborne, Vicki, et al.. (2010). Incidence of Venous Thromboembolism in Users of Strontium Ranelate. Drug Safety. 33(7). 579–591. 24 indexed citations

Layton, Deborah, Lynda Wilton, & Saad Shakir. (2009). Examining the Tolerability of the Non-Sedating Antihistamine Desloratadine. Drug Safety. 32(2). 169–179. 8 indexed citations

10.

Layton, Deborah, Lynda Wilton, A. Boshier, et al.. (2006). Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine. Drug Safety. 29(10). 897–909. 26 indexed citations

11.

Marshall, Vanessa, Lynda Wilton, & Saad Shakir. (2006). Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study. Acta Diabetologica. 43(1). 6–13. 10 indexed citations

12.

Koren, Gideon, Thomas R. Einarson, Lynda Wilton, et al.. (2006). Exposure to Mirtazapine During Pregnancy. The Journal of Clinical Psychiatry. 67(8). 1280–1284. 86 indexed citations

13.

Wilton, Lynda, et al.. (2006). Ophthalmological Events in Patients Receiving Risedronate. Drug Safety. 29(2). 151–160. 15 indexed citations

14.

Wilton, Lynda, et al.. (2005). Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. Osteoporosis International. 16(12). 1989–1998. 23 indexed citations

15.

Acharya, Nayan, Ruth Pickering, Lynda Wilton, & Saad Shakir. (2005). The Safety and Effectiveness of Newer Antiepileptics: A Comparative Postmarketing Cohort Study. The Journal of Clinical Pharmacology. 45(4). 385–393. 14 indexed citations

16.

Mann, Ronald D., Pipasha Biswas, Shayne N. Freemantle, G. L. Pearce, & Lynda Wilton. (2000). The pharmacovigilance of tamsulosin: event data on 12 484 patients. British Journal of Urology. 85(4). 446–450. 24 indexed citations

17.

Wilton, Lynda, et al.. (1996). The safety of finasteride used in benign prostatic hypertrophy: a non‐interventional observational cohort study in 14 772 patients. British Journal of Urology. 78(3). 379–384. 60 indexed citations

18.

Inman, W.H.W., G. L. Pearce, & Lynda Wilton. (1994). Safety of fluconazole in the treatment of vaginal candidiasis. European Journal of Clinical Pharmacology. 46(2). 115–8. 49 indexed citations

19.

Inman, W.H.W., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1993). PEM report number 6. Paroxetine. Pharmacoepidemiology and Drug Safety. 2(4-5). 393–422. 14 indexed citations

20.

Inman, W.H.W., Kiyoshi Kubota, Gillian Pearce, & Lynda Wilton. (1993). PEM report number 7. Itraconazole. Pharmacoepidemiology and Drug Safety. 2(4-5). 423–443. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact